Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 09, 2019
Document And Entity Information    
Entity Registrant Name Tonix Pharmaceuticals Holding Corp.  
Entity Central Index Key 0001430306  
Document Type 10-Q  
Trading Symbol TNXP  
Document Period End Date Mar. 31, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity's Reporting Status Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   6,089,728
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2019